+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticonvulsants"

From
From
Dystonia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dystonia Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 369 Pages
  • Global
From
From
Paresthesia Treatment - Global Strategic Business Report - Product Thumbnail Image

Paresthesia Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 381 Pages
  • Global
From
Phenobarbital - Global Strategic Business Report - Product Thumbnail Image

Phenobarbital - Global Strategic Business Report

  • Report
  • July 2025
  • 362 Pages
  • Global
From
Neuralgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Neuralgia Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 276 Pages
  • Global
From
From
Krabbe Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Krabbe Disease Treatment - Global Strategic Business Report

  • Report
  • July 2025
  • 194 Pages
  • Global
From
Acute Repetitive Seizures - Global Strategic Business Report - Product Thumbnail Image

Acute Repetitive Seizures - Global Strategic Business Report

  • Report
  • July 2025
  • 180 Pages
  • Global
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 193 Pages
  • Global
From
From
West Syndrome Market Report and Forecast 2025-2034 - Product Thumbnail Image

West Syndrome Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
Seizures Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Seizures Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Restless Legs Syndrome Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Restless Legs Syndrome Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Infantile Spasm Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Infantile Spasm Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Dravet Syndrome (DS) Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Dravet Syndrome (DS) Epidemiology Forecast 2025-2034

  • Report
  • May 2025
  • 150 Pages
  • Global
From
Seizures Pipeline Insight Analysis Report - Product Thumbnail Image

Seizures Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
Loading Indicator

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics. The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more